Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Am J Surg Pathol. 2021 Aug 1;45(8):1075–1081. doi: 10.1097/PAS.0000000000001647

Figure 2:

Figure 2:

Immunohistochemical stainings on stage 4S neuroblastomas. A: Tumor expressing MYCN protein with a strong and heterogeneous staining pattern, B: Tumor expressing MYCN protein with a moderate and uniform staining pattern, C: Tumor expressing MYC protein, D: Tumor expressing no MYC-family protein expression (D-1: MYCN staining, D-2: MYC staining). BD: bile duct positively stained for this marker. Note: MYCN staining without counter staining and MYC staining with Hematoxylin staining.